Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FXL91
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,789
Award facts
- Contract value 100% obligated
- $39,788.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $39,788.55 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 14, 2025. IMFINZI (durvalumab) is an oncology immunotherapy medication used in cancer treatment, reflecting the broad pharmaceutical portfolio that AmerisourceBergen supplies to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's $999.99 billion Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen has demonstrated consistent capability to fulfill federal procurement requirements through competitive awards across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FXL91?
SPE2DB25FXL91 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FXL91 worth?
The government has obligated $39,789 on SPE2DB25FXL91.
Is contract SPE2DB25FXL91 an order under another contract?
Yes. SPE2DB25FXL91 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXL91 competed?
The extent of competition for SPE2DB25FXL91 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award